Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Cohance Lifesciences Ltd.
NSE: COHANCE
|
BSE: 543064
|
ISIN: INE03QK01018
|
Industry: Pharmaceuticals
|
Expensive Underperformer
307.2500
-4.70
(
-1.51
%)
NSE
Apr 02, 2026
15:31 PM
75.42% Fall from 52W High
Volume:
280.2K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Cohance Lifesciences Ltd.
29 Feb 2024
307.25
-1.51%
SUVEN PHARMACEUTICALS LIMITED
Sell:
Cohance Lifesciences Ltd.
by
Geojit BNP Paribas
Target: 571
Recommendation
Target
Geojit BNP Paribas
Cohance Lifesciences has lost
-64.91%
in the last 6 Months
More from Cohance Lifesciences Ltd.
Recommended
Five Interesting Stocks Today - April 2, 2026
The Baseline |
02 Apr 2026, 06:00PM
Market closes higher on strong rupee and value buying
Trendlyne Marketwatch |
02 Apr 2026
Gold rising, crude expensive, portfolio volatile: the new financial year begins
The Baseline |
02 Apr 2026